This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pettorruso M, di Giannantonio M, De Risio L, Martinotti G, Koob GF. A light in the darkness: repetitive transcranial magnetic stimulation (rTMS) to treat the hedonic dysregulation of addiction. J Addict Med. 2020;14:272–4.
UNODC, World Drug Report 2023 (United Nations publication, 2023).
Kwako LE, Schwandt ML, Ramchandani VA, Diazgranados N, Koob GF, Volkow ND, et al. Neurofunctional domains derived from deep behavioral phenotyping in alcohol use disorder. Am J Psychiatry. 2019;176:744–53. https://doi.org/10.1176/appi.ajp.2018.18030357.
Brucar LR, Feczko E, Fair DA, Zilverstand A. Current approaches in computational psychiatry for the data-driven identification of brain-based subtypes. Biol Psychiatry. 2023;93:704–16.
Clementz BA, Sweeney JA, Hamm JP, Ivleva EI, Ethridge LE, Pearlson GD, et al. Identification of distinct psychosis biotypes using brain-based biomarkers. Am J Psychiatry. 2016;173:373–84. https://doi.org/10.1176/appi.ajp.2015.14091200.
Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486:346–52. https://doi.org/10.1038/nature10983.
Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, et al. Resting-state connectivity biomarkers define neuro- physiological subtypes of depression. Nat Med. 2017;23:28–38. [published correction appears in Nat Med 2017;23:264]
Insel T, Cuthbert B, Garvey M, Heinssen R, Pine D, Quinn K, et al. Research domain criteria (rdoc): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748–51.
Bogdan R, Hatoum AS, Johnson EC, Agrawal A. The genetically informed neurobiology of addiction (GINA) model. Nat Rev Neurosci. 2023;24:40–57. https://doi.org/10.1038/s41583-022-00656-8.
Kwako LE, Momenan R, Litten RZ, Koob GF, Goldman D. Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders. Biol Psychiatry. 2016;80:179–89.
Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology. 2010;35:217–38.
Witkiewitz K, Stein ER, Votaw VR, Hallgren KA, Gibson BC, Boness CL, et al. Constructs derived from the addiction cycle predict alcohol use disorder treatment outcomes and recovery 3 years following treatment. Psychol Addict Behav. 2023;37:376–89.
Zhu T, Becquey C, Chen Y, Lejuez CW, Li CR, Bi J. Identifying alcohol misuse biotypes from neural connectivity markers and concurrent genetic associations. Transl Psychiatry. 2022;12:253. https://doi.org/10.1038/s41398-022-01983-1.
Voon V, Grodin E, Mandali A, Morris L, Doñamayor N, Weidacker K, et al. Addictions neuroimaging Assessment (ANIA): Towards an integrative framework for alcohol use disorder. Neurosci Biobehav Rev. 2020;113:492–506. https://doi.org/10.1016/j.neubiorev.2020.04.004.
Mann K, Roos CR, Hoffmann S, Nakovics H, Leménager T, Heinz A, et al. Precision medicine in alcohol dependence: a controlled trial testing pharmacotherapy response among reward and relief drinking phenotypes. Neuropsychopharmacology. 2018;43:891–9. https://doi.org/10.1038/npp.2017.282.
Author information
Authors and Affiliations
Contributions
Conceptualization: MP; Investigation: FDC, GdA; Methodology: MP, GDL, LDR; Writing - original draft: MP, LDR, FDC, GdA; Writing - review and editing: GDL, GM.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pettorruso, M., Di Lorenzo, G., De Risio, L. et al. Addiction biotypes: a paradigm shift for future treatment strategies?. Mol Psychiatry (2024). https://doi.org/10.1038/s41380-024-02423-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41380-024-02423-w